Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (221-230 of 669) with videos related to

Pageof 67
Sort By:
Frontiers in Pharmacology|November 29, 2023
Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDRYuval Bin Kanner, Qiu-Xu Teng, Assaf Ganoth, et al.
Medical Review (2021)|March 22, 2024
Nanotechnology-based delivery systems to overcome drug resistance in cancerHarsh Patel, Jiaxin Li, Letao Bo, et al.
The Journal of Biological Chemistry|May 24, 2003
MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenineYanping Guo, Elena Kotova, Zhe-Sheng Chen, et al.
Molecular Cancer|April 23, 2022
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cellsLei Zhang, Yidong Li, Chaohua Hu, et al.
European Journal of Medical Research|January 10, 2026
GLP-1 agonists reduce right ventricular mitochondrial dysfunction by inhibiting the GSK3β-Drp1 signalling in pulmonary hypertensionLin Zhao, Yanghong Liu, Ziwei Ou, et al.
Discover Oncology|December 20, 2024
ALKBH1: emerging biomarker and therapeutic target for cancer treatmentMing Zhu Xiao, Jin Yin Fu, Le Tao Bo, et al.
Medical Review (2021)|December 12, 2024
Cancer nuclear envelope rupture and repair in taxane resistanceAna P Xu, Lucy B Xu, Elizabeth R Smith, et al.
Frontiers in Pharmacology|February 29, 2024
Combating antimicrobial resistance: the silent warLetao Bo, Haidong Sun, Yi-Dong Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 8, 2024
Targeting anoikis resistance as a strategy for cancer therapyYumin Wang, Sihang Cheng, Joshua S Fleishman, et al.
Frontiers in Pharmacology|January 22, 2024
Cell death in cancer chemotherapy using taxanesAna P Xu, Lucy B Xu, Elizabeth R Smith, et al.
Pageof 67

Showing results (221-230 of 669) with videos related to

Sort By:
Pageof 67
Frontiers in Pharmacology|November 29, 2023
Cytotoxicity and reversal effect of sertraline, fluoxetine, and citalopram on MRP1- and MRP7-mediated MDRYuval Bin Kanner, Qiu-Xu Teng, Assaf Ganoth, et al.
Medical Review (2021)|March 22, 2024
Nanotechnology-based delivery systems to overcome drug resistance in cancerHarsh Patel, Jiaxin Li, Letao Bo, et al.
The Journal of Biological Chemistry|May 24, 2003
MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenineYanping Guo, Elena Kotova, Zhe-Sheng Chen, et al.
Molecular Cancer|April 23, 2022
CDK6-PI3K signaling axis is an efficient target for attenuating ABCB1/P-gp mediated multi-drug resistance (MDR) in cancer cellsLei Zhang, Yidong Li, Chaohua Hu, et al.
European Journal of Medical Research|January 10, 2026
GLP-1 agonists reduce right ventricular mitochondrial dysfunction by inhibiting the GSK3β-Drp1 signalling in pulmonary hypertensionLin Zhao, Yanghong Liu, Ziwei Ou, et al.
Discover Oncology|December 20, 2024
ALKBH1: emerging biomarker and therapeutic target for cancer treatmentMing Zhu Xiao, Jin Yin Fu, Le Tao Bo, et al.
Medical Review (2021)|December 12, 2024
Cancer nuclear envelope rupture and repair in taxane resistanceAna P Xu, Lucy B Xu, Elizabeth R Smith, et al.
Frontiers in Pharmacology|February 29, 2024
Combating antimicrobial resistance: the silent warLetao Bo, Haidong Sun, Yi-Dong Li, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 8, 2024
Targeting anoikis resistance as a strategy for cancer therapyYumin Wang, Sihang Cheng, Joshua S Fleishman, et al.
Frontiers in Pharmacology|January 22, 2024
Cell death in cancer chemotherapy using taxanesAna P Xu, Lucy B Xu, Elizabeth R Smith, et al.
Pageof 67